Signal antonymy unique to myelodysplastic marrows correlates with altered expression of E2F1

British Journal of Haematology

Volumn 109, Issue 2, 2000, Pages 376-381

  Mundle, Suneel D ^a   Mativi, B Yifwayimare ^a   Cartlidge, Jonathan D ^a   Dangerfield, Bruce ^a   Broady Robinson, LaTanya ^a   Li, Biarou ^a   Shetty, Vilasini ^a   Venugopal, Parameswaran ^a   Gregory, Stephanie A ^a   Preisler, Harvey D ^a   Raza, Azra ^a  

^a RUSH CANCER INSTITUTE   (United States)

Author keywords

Apoptosis; DNA synthesis; E2F1; Myelodysplastic syndromes; Signal antonymy

Indexed keywords

TRANSCRIPTION FACTOR E2F;

ACUTE MYELOBLASTIC LEUKEMIA; APOPTOSIS; ARTICLE; BONE MARROW; CELL CYCLE S PHASE; CLINICAL ARTICLE; CONTROLLED STUDY; GENE ACTIVITY; GENE CONTROL; GENE EXPRESSION; GENE INDUCTION; HUMAN; HUMAN CELL; MYELODYSPLASTIC SYNDROME; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

APOPTOSIS; BONE MARROW CELLS; CARRIER PROTEINS; CELL CYCLE PROTEINS; CELL DIVISION; DNA-BINDING PROTEINS; E2F TRANSCRIPTION FACTORS; E2F1 TRANSCRIPTION FACTOR; HUMANS; IN SITU NICK-END LABELING; MYELODYSPLASTIC SYNDROMES; RNA, MESSENGER; S PHASE; TRANSCRIPTION FACTOR DP1; TRANSCRIPTION FACTORS;

EID: 0034038687     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2000.01937.x     Document Type: Article

References (23)

1. Clark, D.M. & Lampert, I.A. (1990) Apoptosis is a common histopathological finding in myelodysplasia: the correlate of ineffective hematopoiesis. Leukemia and Lymphoma, 2, 415-418.
2. DeGregori, J., Leone, G., Miron, A., Jakoi, L. & Nevins, J.R. (1997) Distinct roles for E1F proteins in cell growth control and apoptosis. Biochemistry, 94, 7245-7250.
3. Hellstrom-Lindberg, E., Kanter-Lewensohn, L. & Ost, A. (1997) Morphological changes and apoptosis in bone marrow from patients with myelodysplastic syndromes treated with granulocyte-CSF and erythropoietin. Leukemia Research, 21, 415-425.
4. Hibner, U. & Coutinho, A. (1994) Signal antonymy: a mechanism for apoptosis induction. Cell Death and Differentiation, 1, 33-37.
5. Hsieh, J.K., Fredersdorf, S., Kouzarides, T., Martin, K. & Lu, X. (1997) E2F1-induced apoptosis requires DNA binding but not transactivation and is inhibited by the retinoblastoma protein through direct interaction. Genes and Development, 11, 1840-1852.
6. Hunt, K.K., Deng, J., Lie, T.-J., Wilson-Heiner, M., Swisher, S.G., Clayman, G. & Hung, M.-C. (1997) Adenovirus-mediated overexpression of the transcription factor E2F1 induces apoptosis in human breast and ovarian carcinoma cell lines and does not require p53. Cancer Research, 57, 4722-4726.
7. Jonveaux, P., Fenaux, P., Quiquandon, I., Pignon, J.M., Lai, J.L., Loucheux-Lefebvre, M.H., Goossens, M., Bauters, F. & Berger, R. (1991) Mutations in the p53 gene in myelodysplastic syndromes. Oncogene, 6, 2243-2247.
8. Kowalik, T.F., DeGregory, J., Schwarz, J.K. & Nevins, J.R. (1995) E2F1 overexpression in quiescent fibroblasts leads to induction of cellular DNA synthesis and apoptosis. Journal of Virology, 69, 2491-2500.
9. Mundle, S., Iftikhar, A., Shetty, V., Dameron, S., Wright-Quinones, Signal Antonymy and Altered E2F1 in MDS 381 V., Marcus, B., Loew, J., Gregory, S. & Raza, A. (1994) Novel in situ double labeling for simultaneous detection of proliferation and apoptosis. Journal of Histochemistry and Cytochemistry, 42, 1533-1537.
10. Mundle, S., Venugopal, P., Cartlidge, J., Pandav, D., Broady-Robinson, L., Gezer, S., Robin, E., Rifkin, S., Klein, M., Alston, D., Hernandez, B., Rosi, D., Alvi, S., Shetty, V., Gregory, S.A. & Raza, A. (1996) Indication of an involvement of interleukin-1 converting enzyme-like protease in intramedullary apoptotic cell death in the bone marrow of patients with myelodysplastic syndromes. Blood, 88, 2640-2647.
11. Mundle, S.D., Mativi, B.Y., Bagai, K., Feldman, G., Cheema, P., Gautam, U., Reza, S., Cartlidge, J.D., Venugopal, P., Shetty, V., Gregory, S.A., Robin, E., Rifkin, S., Shah, R. & Raza, A. (1999) Spontaneous down-regulation of fas-associated phosphatase-1 may contribute to excessive apoptosis in myelodysplastic marrows. International Journal of Hematology, 70, 83-90.
12. Padua, R.A., Guinn, B.A., Al-Sabah, A.I., Smith, M., Taylor, C., Pettersson, T., Ridge, S., Carter, G., White, D., Oscier, D., Chervet, S. & West, R. (1998) Ras, Fms, and p53 mutations and poor clinical outcome in myelodysplasias: a 10-year follow-up. Leukemia, 12, 887-892.
13. Parcharidou, A., Raza, A., Economopoulos, T., Papageorgiou, E., Anagnostou, D., Papadaki, T. & Raptis, S. (1999) Excessive apoptosis of bone marrow cells as evaluated by the in situ end labelling (ISEL) technique may be the basis for ineffective hematopoiesis in patients with myelodysplastic syndromes. European Journal of Haematalogy, 62, 19-26.
14. Parker, J.E. & Mufti, G.J. (1998) Ineffective haematopoiesis and apoptosis in myelodysplastic syndromes. British Journal of Haematology, 101, 220-230.
15. Phillips, A.C., Bates, S., Ryan, K.M., Helin, K. & Vousden, K.H. (1997) Induction of DNA synthesis and apoptosis are separable functions of E2F1. Genes and Development, 11, 1853-1863.
16. Preudhomme, C., Vachee, A., Lepelley, P., Vanrumbeke, M., Zandecki, M., Quesnel, B., Cosson, A. & Fenaux, P. (1994) Inactivation of retinoblastoma gene appears to be very uncommon in myelodysplastic syndromes. British Journal of Haematology, 87, 61-67.
17. Rajapaksa, R., Ginzton, N., Rott, L.S. & Greenberg, P.L. (1996) Altered oncoprotein expression and apoptosis in myelodysplastic syndrome marrow cells. Blood, 88, 4275-4287.
18. Raza, A., Gezer, S., Mundle, S., Borok, R., Rifkin, S., Iftikhar, A., Shetty, V., Parcharidou, A., Loew, J., Alvi, S., Chaney, C., Showel, J., Gregory, S. & Preisler, H. (1995) Apoptosis in bone marrow biopsies involving stromal and hematopoietic cells in 45 patients with myelodysplastic syndromes. Blood, 86, 268-276.
19. Shan, B. & Lee, W.-H. (1994) Deregulated expression of E2F1 induces S-phase entry and leads to apoptosis. Molecular and Cellular Biology, 14, 8166-8173.
20. Slansky, J.E. & Farnham, P.J. (1996) Introduction to the E2F family: protein structure and gene regulation. Current Topics in Microbiology and Immunology, 208, 1-30.
21. Wang, S., Nath, N., Minden, A. & Chellappan, S. (1999) Regulation of Rb and E2F1 by signal transduction cascades: divergent effects of JNK1 and p38 kinases. EMBO Journal, 18, 1559-1570.
22. White, E. (1994) p53, guardian of Rb. Nature, 371, 21-22.
23. Wu, X. & Levine, A.J. (1994) p53 and E2F1 cooperate to mediate apoptosis. Biochemistry, 91, 3602-3606.